In cells, miR-185 suppresses cancer formation by inducing cell cycle arrest and apoptosis by targeting Ras Homolog-MTORC1 Binding (RHEB), RPTOR Independent Companion of MTOR Complex 2 (RICTOR), and AKT Serine/Threonine Kinase 1 (AKT1) [144]. The gene discussed is AKT1; the disease is cancer.